text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323233/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: CDPH VBL

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323234/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323238/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323244/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323257/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323260/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323270/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323282/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323283/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323284/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323288/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323297/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323300/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323313/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323315/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323333/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323335/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323338/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323340/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323343/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323352/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323355/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323362/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323370/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323371/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323376/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323380/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323388/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323392/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323394/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323395/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323404/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323409/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323413/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323416/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323419/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323421/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323431/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323432/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323437/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323446/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323447/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323449/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323467/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323470/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323497/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323499/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323503/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323507/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323512/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323514/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323518/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323520/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323529/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323531/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323562/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323564/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323581/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323586/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323591/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323599/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323600/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323625/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323635/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323636/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323637/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323640/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323643/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323644/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323646/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323647/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323652/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323657/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323686/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323695/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323702/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323705/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323706/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323707/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323710/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323741/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323747/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323749/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323848/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323855/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323863/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323870/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323883/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323884/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323900/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323904/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323909/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323910/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323917/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323918/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323926/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000323933/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324282/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324329/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324330/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324332/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324381/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324385/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324392/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324399/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324406/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324409/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324415/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324422/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324433/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324434/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324475/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324480/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324516/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324517/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324519/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324529/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324543/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324545/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324547/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324548/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324618/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324620/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324625/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324629/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324630/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324641/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324647/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324654/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324656/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324663/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324668/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324682/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324684/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324685/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324687/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324699/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324702/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324703/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325174/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325182/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325186/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325190/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325195/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325198/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325200/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325201/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325208/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325212/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325222/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325227/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325236/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325255/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325260/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325261/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325264/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325266/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325271/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325280/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325284/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325304/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325333/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325339/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325341/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325347/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325348/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325354/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325358/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325367/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325377/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325380/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325382/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325388/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325391/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325398/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325400/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325406/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325407/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325410/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325414/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325415/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325417/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325418/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325420/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325421/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325434/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325448/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325455/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325457/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325459/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325463/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325475/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325476/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325488/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325511/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325515/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325523/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325524/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325529/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325539/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325540/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325541/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325546/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325551/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325558/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325565/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325570/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325573/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325575/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325576/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325581/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325583/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325590/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325592/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325593/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325594/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325596/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325600/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325603/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325609/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325612/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325618/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325624/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325628/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325636/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325637/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325641/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325646/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325648/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325650/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325658/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325661/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325670/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325683/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325684/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325687/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325690/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325693/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325696/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325700/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325703/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325709/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325713/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325715/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325719/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325724/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325725/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325728/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325729/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325730/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325735/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325736/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325743/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325746/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325750/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325757/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325761/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325766/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325772/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325795/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325796/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325798/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325821/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325848/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325855/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325858/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325875/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325885/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325887/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325890/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325897/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325898/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325908/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325913/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325921/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325922/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325927/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325934/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325940/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325941/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325948/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325956/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325969/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325970/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325985/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325989/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325990/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325996/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326013/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326035/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326038/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326040/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326045/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326046/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326047/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326048/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326049/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326053/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326058/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326063/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326077/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326078/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326079/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326092/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326093/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326098/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326105/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326115/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326118/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326123/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326126/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326128/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326133/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326134/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326138/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326151/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326157/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326158/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326159/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326164/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326175/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326181/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326182/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326191/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance